Overview
Indications
Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: the management of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis • tendonitis • bursitis • acute gout • pain • primary dysmenorrhea
Boxed Warning
FDA Black Box Warning
Cardiovascular Thrombotic Events Gastrointestinal Bleeding, Ulceration, and Perforation • 5.1 see Warnings and Precautions () Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fa
Contraindications
When this intervention should not be used
Naproxen tablets and naproxen sodium tablets are contraindicated in the following patients: • 5.7 5.9 see Warnings and Precautions (,) Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [] • 5.7 5.8 see Warnings and Prec
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
54 trials linked to this intervention
Recent Trials
Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With Dysmenorrhea
Mechanistic Characterization of Uterine Pain
Duloxetine for LBP
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Naproxen (substance)
- SNOMED CT
- 372588000
- UMLS CUI
- C0027396
- RxNorm CUI
- 7258
- Labeler
- A-S Medication Solutions
Clinical Data
This intervention maps to 14 entities in the Healos knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.